Article
Preferred mexiletine block of human sodium channels with IVS4 mutations and its pH-dependence.
Pharmacogenetics and genomics - 1 Apr 2005
Mohammadi Bahram, Jurkat-Rott Karin, Alekov Alexi, Dengler Reinhard, Bufler Johannes, Lehmann-Horn Frank
Abstract excerpt
The effects of extracellular pH (6.2, 7.4 and 8.2) and 0.1 mM mexiletine, a channel blocker of the lidocaine type, are studied on two mutations of the fourth voltage sensor of the Nav1.4 sodium channel, R1448H/C. The fast inactivated channel state to which mexiletine preferentially binds is destabilized by the mutations. By contrast to the expected low response of R1448H/C carriers, mexiletine is particularly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
